Entry |
|
Name |
Parsaclisib (USAN/INN) |
Formula |
C20H22ClFN6O2
|
Exact mass |
432.1477
|
Mol weight |
432.88
|
Structure |
|
Simcomp |
|
Class |
Antineoplastic
DG03139 PI3K inhibitor
|
Remark |
|
Efficacy |
Antineoplastic, Phosphatidylinositol 3-kinase inhibitor |
Target |
|
Pathway |
hsa04662 | B cell receptor signaling pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
L01EM05 Parsaclisib
D11437 Parsaclisib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03139 PI3K inhibitor
DG03025 Parsaclisib
D11437 Parsaclisib
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Phosphotransferase
PIK3CD
D11437 Parsaclisib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03139 PI3K inhibitor
DG03025 Parsaclisib
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 30
1 N5x N 6.8600 -15.4000
2 C8x C 6.8600 -16.8000
3 N5x N 8.0500 -17.5000
4 C8y C 9.3100 -16.8000
5 C8y C 9.3100 -15.4000
6 C8y C 8.0500 -14.7000
7 N4y N 10.6400 -17.2200
8 N5x N 11.4100 -16.1000
9 C8y C 10.6400 -14.9800
10 C1c C 11.8300 -17.9200
11 C8y C 13.0200 -17.2200
12 C8y C 14.2381 -17.9101
13 C8y C 15.3748 -17.2003
14 C8y C 15.4334 -15.8003
15 C8y C 14.2153 -15.1102
16 C8x C 13.0086 -15.8200
17 C1a C 11.8300 -19.3200
18 N1a N 8.0328 -13.3001
19 C1a C 11.0954 -13.6561
20 X Cl 14.2040 -13.7200
21 X F 16.6067 -15.1102
22 O2a O 14.1984 -19.3188
23 C1y C 16.6121 -17.9205
24 C1x C 16.7532 -19.3105
25 N1x N 18.1187 -19.6058
26 C5x C 18.8215 -18.3984
27 C1x C 17.8904 -17.3569
28 O5x O 20.2215 -18.2563
29 C1b C 15.3996 -20.0582
30 C1a C 15.3658 -21.4896
BOND 33
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 2
10 5 9 1
11 7 10 1
12 10 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 10 17 1 #Down
20 6 18 1
21 9 19 1
22 15 20 1
23 14 21 1
24 12 22 1
25 23 13 1 #Up
26 23 24 1
27 24 25 1
28 25 26 1
29 26 27 1
30 23 27 1
31 26 28 2
32 22 29 1
33 29 30 1
|